A chiral molecule-based magnet [Mn (-pnH) (HO)][Mn(CN)]·HO (-pn = -1,2-diaminopropane), ·2HO (222), has been obtained, which has a two-dimensional (2D) square network of cyanide-bridged Mn-Mn ions. The crystallographic research on this coordination polymer indicates that it is robust enough to transform the single-crystal structure upon dehydration as well as rehydration. Meanwhile, the magnetic property changes are reversibly associated with the structural phase transitions. The complete reversibility upon dehydration/rehydration was demonstrated using in situ X-ray diffraction from the as-prepared ·2HO to the dehydrated [Mn (-pnH)][Mn(CN)], , then rehydrated to [Mn (-pnH) (HO)][Mn(CN)]·HO, , and dehydrated again to [Mn (-pnH)][Mn(CN)], . Neither the space groups nor the crystal axes changed during the dehydration/rehydration process. The dehydration is considered to be associated with a change in the coordination of the -pnH from one 2D layer to the neighboring one involving a proton transfer and is accompanied by new cyanide bridging of Mn and Mn ions formed between the 2D sheet. Corresponding to the 2D to three-dimensional (3D) structural transition, the study of magnetic properties reveals that the Curie temperature of long-range magnetic ordering for ( = 45 K) is more than double that for ·2HO ( = 21 K).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.inorgchem.4c02218 | DOI Listing |
Introduction: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, non-malignant hematologic disease characterized by complement-mediated hemolysis (with or without hemoglobinuria), fatigue, increased susceptibility to thrombosis, and bone marrow dysfunction. The development of complement inhibitors has transformed outcomes for patients with PNH, but patients may still experience pharmacodynamic breakthrough hemolysis (BTH), which can be caused by exposure to a complement amplifying condition (CAC), such as vaccination, infection, or surgery.
Materials And Methods: A 13-member expert panel used a validated methodology (a RAND/UCLA modified Delphi panel) to develop consensus on how to classify pharmacodynamic BTH in patients with complement-inhibitor treated PNH.
Hematol Rep
October 2024
Mayo Clinic, Rochester, MN 55905, USA.
: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, life-threatening disease characterized by complement-mediated hemolysis. OPERA is the first US longitudinal real-world study on C3 inhibitor therapy, known as pegcetacoplan. : OPERA enrolled US patients with PNH, age ≥18, who were prescribed pegcetacoplan, and data were collected from routine care.
View Article and Find Full Text PDFAnn Hematol
November 2024
Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
This study describes the health-related quality of life (HRQoL) and symptom-specific functional impairment of patients with paroxysmal nocturnal hemoglobinuria (PNH) in a real-world setting. US-based adults with PNH treated with a parenterally administered complement inhibitor (PACI) for ≥ 6 months completed an online, cross-sectional, observational survey; a subset of patients also participated in semi-structured qualitative interviews. The survey included the PROMIS 29 + 2 Profile v2.
View Article and Find Full Text PDFInorg Chem
November 2024
Department of Chemistry, Graduate School of Science, Hiroshima University, 1-3-1, Kagamiyama, Higashihiroshima, Hiroshima 739-8526, Japan.
A chiral molecule-based magnet [Mn (-pnH) (HO)][Mn(CN)]·HO (-pn = -1,2-diaminopropane), ·2HO (222), has been obtained, which has a two-dimensional (2D) square network of cyanide-bridged Mn-Mn ions. The crystallographic research on this coordination polymer indicates that it is robust enough to transform the single-crystal structure upon dehydration as well as rehydration. Meanwhile, the magnetic property changes are reversibly associated with the structural phase transitions.
View Article and Find Full Text PDFDalton Trans
October 2024
Department of Chemistry, School of Sciences and Humanities, Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana 010000, Kazakhstan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!